Intrinsic Value

Regulus Therapeutics Inc. (RGLS)

$2.89

+0.01 (+0.35%)

Enterprise Value -2,942.63
Net Debt -20.73
Equity Value -2,921.91
Shares Outstanding 18.96
Equity Value Per Share -154.11



Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt